Back
Direxion Daily S&P Biotech Bear 3X Shares Vs. Nektar Therapeutics Industry Stock Comparison
Sell
34
LABD
Direxion Daily S&P Biotech Bear 3X Shares
Last Price:
$5.83
Seasonality Move:
13.52%
Buy
59
NKTR
Nektar Therapeutics
Last Price:
$25.74
Seasonality Move:
4.65%
Sell
34
Direxion Daily S&P Biotech Bear 3X Shares (LABD)
is a Sell
Is Direxion Daily S&P Biotech Bear 3X Shares a Buy, Sell or Hold?
-
The current Direxion Daily S&P Biotech Bear 3X Shares [LABD] share price is $5.83. The Score for LABD is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
LABD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $25.72. The Score for NKTR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LABD Stock Price Chart
What is Direxion Daily S&P Biotech Bear 3X Shares's stock price today?
-
The Direxion Daily S&P Biotech Bear 3X Shares share price today is $5.83The current trend is moderately bullish and LABD is experiencing selling pressure, which indicates risk of future bearish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $25.72Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
LABD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.67 | Buy |
Relative Strength Index (14 RSI): | 36.11 | Sell |
Chaikin Money Flow: | -16213588 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.18 - 6.66) | Sell |
Bollinger Bands (100): | (6.46 - 9.7) | Sell |
NKTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.62 | Buy |
Relative Strength Index (14 RSI): | 61.8 | Buy |
Chaikin Money Flow: | 677331 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.56 - 25.12) | Buy |
Bollinger Bands (100): | (8.21 - 22.19) | Buy |
LABD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.49 | Sell |
20-day SMA: | 6.45 | Sell |
50-day SMA: | 6.85 | Sell |
200-day SMA: | 7.38 | Sell |
8-day EMA: | 6.1 | Sell |
20-day EMA: | 4.54 | Buy |
50-day EMA: | 2.48 | Buy |
200-day EMA: | 0.74 | Buy |
NKTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.11 | Buy |
20-day SMA: | 23.68 | Buy |
50-day SMA: | 20.19 | Buy |
200-day SMA: | 15.03 | Buy |
8-day EMA: | 23.52 | Buy |
20-day EMA: | 23.17 | Buy |
50-day EMA: | 20.66 | Buy |
200-day EMA: | 16.42 | Buy |
Direxion Daily S&P Biotech Bear 3X Shares Earnings Growth & LABD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.16 per share, and a decrease next year of $1.84 per share.
Direxion Daily S&P Biotech Bear 3X Shares Technical Analysis
Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nektar Therapeutics Technical Analysis
Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |